Literature DB >> 30561033

Synbindin deficiency inhibits colon carcinogenesis by attenuating Wnt cascade and balancing gut microbiome.

Luoyan Ai1, Yimeng Ren1, Yiting Li1, Haoyan Chen1, Yun Qian1, Shiyuan Lu1, Antao Xu1, Linlin Ren1, Shuliang Zhao1, Zhaofei Chen1, Ying-Xuan Chen1, Jie Xu1, Jing-Yuan Fang1.   

Abstract

The molecular mechanisms that control the development of colorectal cancer (CRC) remain poorly defined. Here we show Synbindin promoted CRC oncogenesis by activating Wnt signaling and altering gut microbiome. Synbindin upregulation in human CRCs was associated with poor patient prognosis. Intestine-specific disruption of Synbindin balanced the disturbed gut microbiota and protected mice against tumor formation in the colitis-associated cancer (CAC) model. The protective role was compromised after gut microbiota depletion. In host, increased goblet cells and mucin2 expression, together with increased intestinal epithelial cells (IECs) apoptosis and decreased epithelial proliferation were observed. Further transcriptomic sequencing identified Wnt signaling a major regulatory node downstream of Synbindin. Combined molecular and cellular characterizations revealed that Synbindin confers Disheveled-3 (DVL3)-based signalosome assembly and acts as a modular scaffold for DVL3 and Axin2 complex, orchestrating the intensity of Wnt signaling. These findings identify a critical role of Synbindin in gut microbiome composition and Wnt signaling activation in colorectal carcinogenesis, and highlight Synbindin as an adaptor protein with multifaceted roles.
© 2018 UICC.

Entities:  

Keywords:  CRC; DVL3; Synbindin; Wnt signaling; gut microbiome

Mesh:

Substances:

Year:  2019        PMID: 30561033     DOI: 10.1002/ijc.32074

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  2 in total

Review 1.  Wnt Signaling: Pathogen Incursion and Immune Defense.

Authors:  Suborno Jati; Tresa Rani Sarraf; Debdut Naskar; Malini Sen
Journal:  Front Immunol       Date:  2019-10-29       Impact factor: 7.561

2.  MCT4 Promotes Hepatocellular Carcinoma Progression by Upregulating TRAPPC5 Gene.

Authors:  Zheyu Niu; Faji Yang; Hongguang Li; Jianlu Wang; Qingqiang Ni; Chaoqun Ma; Huaqiang Zhu; Hong Chang; Xu Zhou; Jun Lu; Hengjun Gao
Journal:  J Hepatocell Carcinoma       Date:  2022-04-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.